Font Size: a A A

Role Of Adjuvant(chemo)radiotherapy For Resected Extrahepatic Cholangiocarcinoma:A Meta-analysis

Posted on:2022-05-07Degree:MasterType:Thesis
Country:ChinaCandidate:X Q ShiFull Text:PDF
GTID:2504306563953819Subject:Oncology
Abstract/Summary:PDF Full Text Request
Objective: Adjuvant(chemo)radiotherapy [A(C)RT)] may be an important supplement to surgery for extrahepatic cholangiocarcinoma(EHCC).However,whether all patients would achieve benefits from A(C)RT and which adjuvant regimen,adjuvant radiotherapy(ART)or adjuvant chemoradiotherapy(ACRT)would be preferred,are still undetermined.The low incidence of EHCC makes it difficult to carry out randomized controlled trials(RCTs),therefore,almost all clinical studies on radiotherapy are retrospective.We have conducted a meta-analysis of these retrospective studies.Methods: We conducted a meta-analysis of current retrospective studies using PubMed,Embase,and Clinical Trials databases.All studies published in English that were related to A(C)RT and which analyzed overall survival(OS),disease-free survival(DFS),or locoregional recurrence-free survival(LRFS)were included.Estimated hazard ratios(HRs)and 95% confidence intervals(CIs)were calculated for OS,DFS,and LRFS.Results: Data from eight studies including 685 patients were included.Our analysis showed that A(C)RT significantly improved OS(HR 0.69,95%CI 0.48-0.97,P=0.03),DFS(HR 0.60,95%CI 0.47-0.76,P<0.0001),and LRFS(HR 0.27,95%CI 0.17-0.41,P<0.00001)of EHCC overall.In subgroups,patients with microscopically positive resection margins(R1)could achieve a benefit from A(C)RT(OS: HR 0.44,95%CI0.27-0.72,P=0.001;DFS: HR 0.38,95%CI 0.18-0.78,P=0.008).No statistically OS difference was observed in negative resection margin(R0)subgroup(HR 0.98,95%CI0.30-3.19,P=0.98).Significant OS benefit was found in patients who received concurrent ACRT(HR 0.40,95%CI 0.26-0.62,P<0.00001),while the result of ART without chemotherapy showed no significant benefit(HR 1.14,95%CI 0.29-4.50,P=0.85).In the distal cholangiocarcinoma subgroup,no significant difference was seen when ACRT and ART were included(HR 0.61,95%CI 0.14-2.72,P=0.52),but a significant difference was seen when analyzing ACRT only(HR 0.29,95%CI 0.13-0.64,P=0.002).Conclusion: A(C)RT improve OS,DFS,and LRFS in EHCC patients,but those with R0 resection margins will not benefit from A(C)RT.ACRT may be superior to ART especially in distal patients.
Keywords/Search Tags:Adjuvant(chemo)radiotherapy, Extrahepatic cholangiocarcinoma, Meta-analysis, Overall survival, Disease-free survival
PDF Full Text Request
Related items